MetLife [MET] vs Globe Life [GL] Detailed Stock Comparison

MetLife Inc.

NYSE
Loading...

Globe Life Inc.

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: MetLife Inc. wins in 7 metrics, Globe Life Inc. wins in 13 metrics, with 0 ties. Globe Life Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric MetLife Inc. Globe Life Inc. Better
P/E Ratio (TTM) 16.15 10.75 Globe Life Inc.
Price-to-Book Ratio 1.76 2.00 MetLife Inc.
Debt-to-Equity Ratio 225.97 52.35 Globe Life Inc.
PEG Ratio -0.48 1.05 Globe Life Inc.
EV/EBITDA 15.07 8.97 Globe Life Inc.
Profit Margin (TTM) 4.38% 19.37% Globe Life Inc.
Operating Margin (TTM) 4.67% 24.24% Globe Life Inc.
EBITDA Margin (TTM) 4.67% 24.24% Globe Life Inc.
Return on Equity 12.02% 20.59% Globe Life Inc.
Return on Assets (TTM) 0.46% 3.33% Globe Life Inc.
Free Cash Flow (TTM) $17.09B $1.25B MetLife Inc.
Dividend Yield 3.03% 0.77% MetLife Inc.
1-Year Return 14.85% 39.21% Globe Life Inc.
Price-to-Sales Ratio (TTM) 0.64 1.98 MetLife Inc.
Enterprise Value $89.84B $14.56B MetLife Inc.
EV/Revenue Ratio 1.17 2.43 MetLife Inc.
Revenue per Share (TTM) $115 $74 MetLife Inc.
Earnings per Share (Diluted) $4.71 $14.07 Globe Life Inc.
Beta (Stock Volatility) 0.73 0.47 Globe Life Inc.
Short % of Float 2.61% 0.01% Globe Life Inc.

MetLife Inc. vs Globe Life Inc. Stock Performance Analysis

Loading Price Chart...

MET
GL

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
MetLife Inc.-1.33%3.89%9.88%26.75%6.11%9.14%
Globe Life Inc.0.38%6.53%7.97%19.72%19.01%20.93%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
MetLife Inc.14.85%60.07%52.38%136.40%146.91%99.01%
Globe Life Inc.39.21%54.39%80.77%177.52%496.42%542.62%

Performance & Financial Health Analysis: MetLife Inc. vs Globe Life Inc.

MetricMETGL
Market Information
Market Cap i$49.60B$12.11B
Market Cap CategoryLarge capLarge cap
10 Day Avg. Volume i3,185,584445,504
90 Day Avg. Volume i3,535,355477,658
Last Close$87.66$167.39
52 Week Range$67.33 - $89.62$116.73 - $169.53
% from 52W High-2.19%-1.26%
All-Time High$89.62 (Jun 15, 2026)$169.53 (Jun 15, 2026)
% from All-Time High-2.19%-1.26%
Growth Metrics
Quarterly Revenue Growth0.28%0.04%
Quarterly Earnings Growth-0.36%0.04%
Financial Health
Profit Margin (TTM) i0.04%0.19%
Operating Margin (TTM) i0.05%0.24%
Return on Equity (TTM) i0.12%0.21%
Debt to Equity (MRQ) i225.9752.35
Cash & Liquidity
Book Value per Share (MRQ)$43.33$75.54
Cash per Share (MRQ)$39.31$5.84
Operating Cash Flow (TTM) i$17.09B$1.40B
Levered Free Cash Flow (TTM) i$-12,738,499,584$1.14B
Dividends
Last 12-Month Dividend Yield i3.03%0.77%
Last 12-Month Dividend i$2.28$1.08

Valuation & Enterprise Metrics Analysis: MetLife Inc. vs Globe Life Inc.

MetricMET (Apr 24, 2026)GL (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i16.1510.75
Forward P/E i6.959.13
PEG Ratio i-0.481.05
Price to Sales (TTM) i0.641.98
Price to Book (MRQ) i1.762.00
Market Capitalization
Market Capitalization i$49.60B$12.11B
Enterprise Value i$89.84B$14.56B
Enterprise Value Metrics
Enterprise to Revenue i1.172.43
Enterprise to EBITDA i15.078.97
Risk & Other Metrics
Beta i0.730.47
Book Value per Share (MRQ) i$43.33$75.54

Financial Statements Comparison: MetLife Inc. vs Globe Life Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricMET (2025)GL (2025)
Revenue/Sales i75.65B5.99B
Cost of Goods Sold iN/AN/A
COGS % of Revenue i0.0%0.0%
Gross Profit iN/AN/A
Gross Margin i0.0%0.0%
Research & Development iN/AN/A
Operating Income (EBIT) iN/AN/A
Operating Margin i0.0%0.0%
EBITDA iN/AN/A
EBITDA Margin i0.0%0.0%
Pre-Tax Income i4.66B1.44B
Pre-Tax Income % of Revenue i6.2%24.0%
Income Tax i1.26B274.74M
Income Tax % of Revenue i1.7%4.6%
Net Income (Profit) i3.40B1.16B
Profit Margin i4.5%19.4%

Balance Sheet & Liquidity Metrics

MetricMET (2025)GL (2025)
Cash & Equivalents i22.03B144.70M
Total Current Assets iN/AN/A
Total Current Assets % of Revenue i0.0%0.0%
Total Current Liabilities iN/AN/A
Total Current Liabilities % of Revenue i0.0%0.0%
Long-Term Debt i18.62B2.32B
Long-Term Debt % of Revenue i24.6%38.7%
Total Shareholders Equity i28.92B5.97B
Retained Earnings i44.29B8.55B
Retained Earnings % of Revenue i58.5%142.6%
Property, Plant & Equipment iN/AN/A

Cash Flow Statement Comparison

MetricMET (2025)GL (2025)
Operating Cash Flow i-873.00M1.16B
Operating Cash Flow % of Revenue i-1.2%19.4%
Capital Expenditures iN/A-142.48M
Free Cash Flow i17.09B1.25B
FCF Margin i22.6%20.9%
Debt Repayment i-2.62B-700.99M
Common Stock Repurchase i-3.88B-880.98M

Short Interest & Institutional Ownership Analysis

MetricMETGL
Shares Short i14.12M6,722
Short Ratio i3.480.01
Short % of Float i2.61%0.01%
Shares Outstanding i655.33M79.09M
Float Shares i544.55M77.91M
% Held by Insiders i16.44%0.67%
% Held by Institutions i76.90%85.43%
% Held by Public i6.66%13.90%

Dividend Analysis & Yield Comparison: MetLife Inc. vs Globe Life Inc.

MetricMETGL
Last 12-Month Dividend i$2.28$1.08
Last 12-Month Dividend Yield i3.03%0.77%
3-Year Avg Annual Dividend i$2.19$0.99
3-Year Avg Dividend Yield i0.78%0.21%
3-Year Total Dividends i$6.56$2.96
Ex-Dividend DateFeb 03, 2026Jan 05, 2026